Caiping Ren

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Stem cells (Dayton, Ohio)

Signal transduction and targeted therapy

Stem cell research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wen Xie, Weidong Liu, Lei Wang, Shasha Li, Zilin Liao, Hongjuan Xu, Yihan Li, Xingjun Jiang, Caiping Ren
Embryonic stem cell related gene regulates alternative splicing of transcription factor 3 to maintain human embryonic stem cells' self-renewal and pluripotency. Stem cells (Dayton, Ohio) 42 (6) (2024)
Wen Xie, Weidong Liu, Lei Wang, Shasha Li, Zilin Liao, Hongjuan Xu, Yihan Li, Xingjun Jiang, Caiping Ren
ESRG regulates alternative splicing of TCF3 to maintain hESCs self-renewal and pluripotency. Stem cells (Dayton, Ohio) (2024)
Shasha Li, Hecheng Zhu, Ming Zhao, Weidong Liu, Lei Wang, Bin Zhu, Wen Xie, Cong Zhao, Yao Zhou, Caiping Ren, Hui Liu, Xingjun Jiang
When stem cells meet COVID-19: recent advances, challenges and future perspectives. Stem cell research & therapy 13 (1) (2022)
Cong Zhao, Wen Xie, Hecheng Zhu, Ming Zhao, Weidong Liu, Zhaoping Wu, Lei Wang, Bin Zhu, Shasha Li, Yao Zhou, Xingjun Jiang, Qiang Xu, Caiping Ren
LncRNAs and their RBPs: How to influence the fate of stem cells? Stem cell research & therapy 13 (1) (2022)
Yuanbo Kang, Weihan He, Caiping Ren, Jincheng Qiao, Qiuyong Guo, Jingyu Hu, Hongjuan Xu, Xingjun Jiang, Lei Wang
Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal transduction and targeted therapy 5 (1) (2020)
Yuanbo Kang, Weihan He, Caiping Ren, Jincheng Qiao, Qiuyong Guo, Jingyu Hu, Hongjuan Xu, Xingjun Jiang, Lei Wang
Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal transduction and targeted therapy 5 (1) (2020)

Caiping Ren.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Caiping Ren